NASDAQ:CNCE - Concert Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$9.44 -0.40 (-4.07 %)
(As of 04/19/2019 02:23 AM ET)
Previous Close$9.84
Today's Range$9.30 - $9.97
52-Week Range$9.30 - $21.00
Volume340,327 shs
Average Volume258,751 shs
Market Capitalization$222.11 million
P/E RatioN/A
Dividend YieldN/A
Beta0.99

SEC Filings

Concert Pharmaceuticals (NASDAQ:CNCE) SEC Filings

DateFilerForm TypeView
04/10/2019
3:34 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/02/2019
3:15 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/02/2019
2:17 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/02/2019
1:50 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
03/01/2019
3:43 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/28/2019
6:26 AM
Concert Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
02/28/2019
6:22 AM
Concert Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/28/2019
6:08 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/07/2019
4:17 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G
View Filing
02/07/2019
4:11 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/07/2019
3:35 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/30/2019
7:46 AM
Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SC 13G/A
View Filing
01/08/2019
3:10 PM
Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
3:09 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
3:08 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
3:07 PM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2019
3:06 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/17/2018
5:56 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/30/2018
3:08 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/23/2018
3:00 PM
Concert Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
View Filing
11/19/2018
4:27 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/15/2018
4:22 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/15/2018
4:21 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/01/2018
6:33 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/01/2018
6:28 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/02/2018
6:30 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/02/2018
6:27 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/11/2018
3:04 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
6:01 PM
Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
6:00 PM
Concert Pharmaceuticals (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
5:59 PM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
5:58 PM
Concert Pharmaceuticals (Issuer)
Fitzgerald Meghan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
5:57 PM
Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
5:57 PM
Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
5:56 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
5:55 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
3:05 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/12/2018
3:56 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/03/2018
6:37 AM
Concert Pharmaceuticals (Filer)
Form DEF 14A
View Filing
05/03/2018
6:33 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/03/2018
6:30 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/19/2018
3:07 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/13/2018
3:51 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4/A
View Filing
04/13/2018
3:50 PM
Concert Pharmaceuticals (Issuer)
HERSCHA LYNETTE (Reporting)
Form 4/A
View Filing
04/13/2018
3:47 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4/A
View Filing
04/13/2018
3:46 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4/A
View Filing
04/10/2018
7:00 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/03/2018
3:22 PM
Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/03/2018
3:21 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/03/2018
3:20 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/03/2018
3:19 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/22/2018
3:06 PM
Concert Pharmaceuticals (Filed by)
Processa Pharmaceuticals, Inc. (Subject)
Form SC 13G
View Filing
03/07/2018
11:15 PM
Concert Pharmaceuticals (Filer)
Form EFFECT
View Filing
03/05/2018
3:29 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2018
6:41 AM
Concert Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/01/2018
6:38 AM
Concert Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
03/01/2018
6:34 AM
Concert Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/01/2018
6:31 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
1:33 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/13/2018
3:35 PM
Concert Pharmaceuticals (Subject)
GLAXOSMITHKLINE PLC (Filed by)
Form SC 13G/A
View Filing
02/09/2018
4:12 PM
Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SC 13G
View Filing
02/05/2018
3:20 PM
Concert Pharmaceuticals (Subject)
TVM Life Science Ventures VI GmbH & Co KG (Filed by)
Form SC 13G/A
View Filing
02/01/2018
3:36 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/01/2018
8:26 AM
BlackRock Inc. (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G
View Filing
01/29/2018
4:43 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/26/2018
3:20 PM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4/A
View Filing
01/26/2018
3:19 PM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 3/A
View Filing
01/24/2018
3:43 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/19/2018
3:34 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/18/2018
3:26 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
5:52 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
5:39 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
5:36 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
5:34 PM
Concert Pharmaceuticals (Issuer)
HERSCHA LYNETTE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
5:30 PM
Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
5:23 PM
BECKER MARC (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
5:21 PM
BECKER MARC (Reporting)
Concert Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/22/2017
3:29 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/22/2017
3:29 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/21/2017
6:40 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/18/2017
6:30 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/06/2017
3:48 PM
Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 4/19/2019 by MarketBeat.com Staff

Featured Article: What is a support level?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel